Seres Therapeutics Ownership | Who Owns Seres Therapeutics?
Seres Therapeutics Ownership Summary
Seres Therapeutics is owned by 40.93% institutional investors, 13.19% insiders, and 45.87% retail investors. Flagship pioneering is the largest institutional shareholder, holding 15.14% of MCRB shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.57% of its assets in Seres Therapeutics shares.
MCRB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Seres Therapeutics | 40.93% | 13.19% | 45.87% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Flagship pioneering | 23.12M | 15.14% | $19.25M |
Fmr | 21.81M | 14.29% | $18.13M |
Vanguard group | 5.87M | 3.85% | $4.88M |
Blackrock | 1.76M | 1.21% | $1.28M |
Millennium management | 1.81M | 1.19% | $1.50M |
Blackrock funding, inc. /de | 1.76M | 1.15% | $1.46M |
Geode capital management | 1.51M | 0.99% | $1.26M |
Vontobel | 938.29K | 0.61% | $779.72K |
Charles schwab investment management | 865.83K | 0.57% | $719.50K |
Northern trust | 721.76K | 0.49% | $522.41K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Flagship pioneering | 23.12M | 5.76% | $19.25M |
Lion point capital, lp | 340.76K | 1.48% | $283.17K |
Providence wealth advisors | 105.00K | 0.07% | $94.01K |
Ironwood investment management | 39.59K | 0.02% | $32.90K |
Bridgeway capital management | 250.00K | 0.00% | $207.75K |
Aries wealth management | 15.00K | 0.00% | $12.46K |
Vontobel | 938.29K | 0.00% | $779.72K |
Cantor fitzgerald, l. p. | 95.74K | 0.00% | $79.56K |
Arete wealth advisors | 20.90K | 0.00% | $17.00K |
Clear creek financial management | 12.95K | 0.00% | $10.76K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 1.81M | 0.00% | 788.76K |
Vontobel | 938.29K | 0.00% | 543.47K |
Ubs group | 342.32K | 0.00% | 307.92K |
Geode capital management | 1.51M | 0.00% | 121.79K |
Charles schwab investment management | 865.83K | 0.00% | 117.11K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 1.76M | - | -5.06M |
Woodline partners lp | - | - | -2.05M |
State street | 339.55K | - | -1.61M |
Bank of america corp /de/ | 105.04K | - | -1.55M |
Handelsbanken fonder ab | - | - | -1.10M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Two sigma investments, lp | 24.41K | - | 24.41K | $20.29K |
Integrated wealth concepts | 10.00K | 0.00% | 10.00K | $8.31K |
Macquarie group | 4.95K | - | 4.95K | $3.58K |
Bell investment advisors | 611.00 | 0.00% | 611.00 | $508.00 |
Sold Out
Holder | Change |
---|---|
Headlands | -10.00 |
Point72 (difc) | -17.00 |
Nelson, van denburg & campbell wealth management group | -20.00 |
Newedge advisors | -200.00 |
Huntington national bank | -230.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 70 | -13.58% | 62,481,139 | -1.44% | 40 | 2.37% | 25 | -3.85% | 17 | -34.62% |
Sep 30, 2024 | 81 | -14.74% | 63,396,268 | -8.26% | 41 | 1.86% | 27 | -41.30% | 26 | -3.70% |
Jun 30, 2024 | 95 | -5.94% | 69,106,531 | -19.34% | 47 | 1.06% | 46 | -2.13% | 27 | -3.57% |
Mar 31, 2024 | 101 | -9.82% | 85,680,215 | -4.29% | 66 | 1.37% | 47 | 6.82% | 28 | -33.33% |
Dec 31, 2023 | 112 | -23.81% | 89,517,414 | -16.63% | 69 | 0.99% | 44 | -40.54% | 42 | 31.25% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 9.72M | 5.57% | 17.04K |
Fidelity Growth Compy Commingled Pl O | 9.44M | 5.55% | 92.60K |
Fidelity Growth Company Fund | 6.79M | 3.90% | - |
Vanguard US Total Market Shares ETF | 4.04M | 2.32% | - |
Vanguard Total Stock Mkt Idx Inv | 3.86M | 2.21% | - |
Fidelity Growth Company K6 | 2.37M | 1.36% | -60.44K |
Fidelity Series Growth Company | 1.64M | 0.94% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 1.45M | 0.83% | - |
Vanguard Explorer Inv | 1.22M | 0.72% | - |
Fidelity Select Biotechnology | 854.35K | 0.50% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 18, 2025 | Young Teresa L. | See Remarks | Sell | $2.70K |
Feb 18, 2025 | Henn Matthew R. | See Remarks | Sell | $3.20K |
Feb 18, 2025 | Shaff Eric D. | CEO and President | Sell | $10.31K |
Feb 18, 2025 | DesRosier Thomas | Chief Legal Officer and EVP | Sell | $3.49K |
Feb 18, 2025 | von Moltke Lisa | See Remarks | Sell | $3.58K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | 5 |
2024 Q4 | - | 10 |
2024 Q3 | - | 7 |
2024 Q2 | - | 6 |
MCRB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools